国产黄片大全在线播放_多毛中国农村熟女吟呻对白_欧洲乱码在线播放_亚洲五月婷婷久久综合色

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > Acinetobacter baumannii Bouvet and Grimont
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號
  • 創(chuàng)e慧谷42號樓B幢401室
Acinetobacter baumannii Bouvet and Grimont
Acinetobacter baumannii Bouvet and Grimont
規(guī)格:
貨期:
編號:B161436
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產(chǎn)品名稱 Acinetobacter baumannii Bouvet and Grimont
商品貨號 B161436
Reports Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As Acinetobacter baumannii
Verified By Whole-genome Sequencing
Strain Designations 1125209
Application Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols
Isolation Sputum
Isolation Date 2014
Geographic Source Italy
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions -80°C or colder
Preceptrol® no
Annotated Genes AAC(6')-Ib7
ADC-2
aadA
adeA
adeB
adeC
adeF
adeG
adeI
adeJ
adeK
adeR
adeS
APH3-Ia
APH(3'')-Ib
APH(3')-VIa
APH(6)-Id
armA
catB8
macA
macB
mexB
mexK
msrE
OXA-23
OXA-66
tet(A)
Type Strain no
MIC Range Susceptible
Colistin: ≤2 µg/mL


Resistant
Amikacin: ≥64 µg/mL
Cefepime: ≥32 µg/mL
Ceftazidime: ≥32 µg/mL
Ceftriaxone: ≥64 µg/mL
Ciprofloxacin: ≥4 µg/mL
Doripenem: ≥8 µg/mL
Imipenem: ≥8 µg/mL
Levofloxacin: ≥8 µg/mL
Meropenem: ≥8 µg/mL
Piperacillin-tazobactam: ≥128/4 µg/mL
Tetracycline: ≥16 µg/mL


Comments This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.

Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition.

Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor International Health Management Associates (IHMA), Inc.
Special Collection Global Priority Superbugs
Chain of Custody ATCC <-- International Health Management Associates (IHMA), Inc.
Patient Age 73
Patient Gender Male
References

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition. Wayne, PA. M100S, 2016.

梅經(jīng)理 17280875617 1438578920
胡經(jīng)理 13345964880 2438244627
周經(jīng)理 17757487661 1296385441
于經(jīng)理 18067160830 2088210172
沈經(jīng)理 19548299266 2662369050
李經(jīng)理 13626845108 972239479